BridgeBio Pharma, Inc. Gains 18.01%

Tue, Dec 28, 2021 at 05:30 PM
BridgeBio Pharma, Inc. Gains 18.01%

BridgeBio Pharma, Inc. (BBIO:NASDAQ) shot up at $13.43, a gain of 18%. On Mon, Dec 27, 2021, BBIO:NASDAQ hit a New 2-Week Low of $11.38. The stock appeared on our News Catalysts scanner on Tue, Dec 28, 2021 at 04:27 PM in the 'INVESTOR UPDATE' category. From Mon, Dec 13, 2021, the stock recorded 55.56% Up Days and 60.00% Green Days

About BridgeBio Pharma, Inc. (BBIO:NASDAQ)

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Oncology and Gene therapy.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.